Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
The CHK2 protein kinase is an important transducer of DNA damage checkpoint signals, and its mutation contributes to hereditary and sporadic cancer. CHK2 activation is triggered by the phosphorylation of Thr68 by the DNA damage-activated ATM kinase. This leads to transient CHK2 dimerization, in part through intermolecular phosphoThr68-FHA domain interactions. Dimerization promotes kinase activation through activation-loop autophosphorylation, but the mechanism of this process has not been clear. The dimeric crystal structure of CHK2, described here, in conjunction with biochemical and mutational data reveals that productive CHK2 dimerization additionally involves intermolecular FHA-kinase domain and FHA-FHA interactions. Ile157, mutated in the Li-Fraumeni cancer-predisposition syndrome, plays a central role in the FHA-kinase domain interface, explaining the lack of dimerization and autophosphorylation of this mutant. In the dimer, the kinase active sites face each other in close proximity, indicating that dimerization may also serve to optimally position the kinase active sites for efficient activation loop transphosphorylation.
- Research Organization:
- Brookhaven National Laboratory (BNL) National Synchrotron Light Source
- Sponsoring Organization:
- Doe - Office Of Science
- DOE Contract Number:
- AC02-98CH10886
- OSTI ID:
- 980537
- Report Number(s):
- BNL--93455-2010-JA
- Journal Information:
- Cell, Journal Name: Cell Journal Issue: 6 Vol. 35; ISSN 0092-8674; ISSN CELLB5
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cellular Inhibition of Checkpoint Kinase 2 (Chk2) and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor PV1019 [7-Nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]
Structural and mechanistic insights into Mps1 kinase activation
Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy
Journal Article
·
Mon Apr 05 00:00:00 EDT 2010
· J. Pharmacol. Exp. Ther.
·
OSTI ID:1006089
Structural and mechanistic insights into Mps1 kinase activation
Journal Article
·
Fri Nov 05 00:00:00 EDT 2010
· J. Cell. Mol. Med.
·
OSTI ID:1006199
Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy
Journal Article
·
Thu Jan 19 23:00:00 EST 2012
· Journal of Structural Biology
·
OSTI ID:1033773